SCHEMBL24925834

SCHEMBL24925834

CCn1ncc(I)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13867879 0.73
SCHEMBL23153984 0.71
Bromide SCHEMBL6855980 0.70 CHRM2 (0.38)
Hydrochloric Acid SCHEMBL17263154 0.70
SCHEMBL12410803 0.68 CHRM2 (0.37)
SCHEMBL2045061 0.68
SCHEMBL4220873 0.68
SCHEMBL24824800 0.68 CHRM2 (0.37)
SCHEMBL12091512 0.68 CHRM2 (0.37)
SCHEMBL23143244 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024073371-A1 AKT1 MODULATORS ALTEROME THERAPEUTICS, INC. (US) 2024-04-04 WO disclosed
US-20230019032-A1 BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2023-01-19 US disclosed